In the large SELECT trial, semaglutide reduced heart attacks, strokes, and cardiovascular death by about 20% in people who were overweight or obese and had established heart disease regardless of whether they had diabetes
As of April 2026, retatrutide (LY3437943) remains an investigational drug in Phase 3 clinical trials
Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer
ALM can appear as a new mole, patch of discoloured skin OR a changing spot in or connected to an existing mole
Almost done We sent the first email to
Unlike semaglutide, which targets one hormone pathway, tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two separate hormone systems involved in appetite regulation and metabolism